We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

74 hedge funds and large institutions have $215M invested in Lumos Pharma, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 74 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

288% more call options, than puts

Call options by funds: $17.5M | Put options by funds: $4.52M

Holders
74
Holders Change
+74
Holders Change %
–
% of All Funds
2.42%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
74
Increased
–
Reduced
–
Closed
–
Calls
$17.5M
Puts
$4.52M
Net Calls
+$13M
Net Calls Change
+$13M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$50.5M +$40.3M +284,295 New
RCM
2
RA Capital Management
Massachusetts
$36.3M +$29M +204,477 New
PC
3
PointState Capital
New York
$19.4M +$15.5M +109,444 New
BFA
4
BlackRock Fund Advisors
California
$13M +$10.3M +73,072 New
First Eagle Investment Management
5
First Eagle Investment Management
New York
$12.7M +$10.1M +71,284 New
TAM
6
Tiverton Asset Management
Delaware
$9.86M +$7.87M +55,556 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$7.96M +$6.35M +44,856 New
WSA
8
Wall Street Associates
California
$6.97M +$5.57M +39,300 New
Invesco
9
Invesco
Georgia
$5.48M +$4.37M +30,855 New
State Street
10
State Street
Massachusetts
$4.68M +$3.73M +26,352 New
Northern Trust
11
Northern Trust
Illinois
$4.3M +$3.43M +24,240 New
BIT
12
BlackRock Institutional Trust
California
$4.08M +$3.25M +22,972 New
SBH
13
Segall Bryant & Hamill
Illinois
$3.97M +$3.17M +22,364 New
MCM
14
Montibus Capital Management
Oregon
$3.44M +$2.74M +19,368 New
Barclays
15
Barclays
United Kingdom
$2.15M +$1.72M +12,112 New
Millennium Management
16
Millennium Management
New York
$1.81M +$1.45M +10,205 New
Bank of New York Mellon
17
Bank of New York Mellon
New York
$1.51M +$1.2M +8,504 New
SCM
18
Sigma Capital Management
Connecticut
$1.48M +$1.18M +8,333 New
Principal Financial Group
19
Principal Financial Group
Iowa
$1.44M +$1.15M +8,089 New
Deutsche Bank
20
Deutsche Bank
Germany
$1.39M +$1.11M +7,858 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$1.38M +$1.1M +7,790 New
TCIM
22
TIAA CREF Investment Management
New York
$1.33M +$1.06M +7,482 New
B
23
Bailard
California
$952K +$760K +5,367 New
EI
24
EAM Investors
California
$943K +$753K +5,315 New
KCM
25
Knoll Capital Management
Florida
$935K +$746K +5,271 New
1
2 3

LUMO Hedge Fund Activity: Q2 2013 in Review

74 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q2 2013, worth a combined $215M.

Buyers outnumbered sellers: 74 funds opened new LUMO positions and 0 closed out — a net gain of 74 holders — while 0 added to existing stakes and 0 trimmed.

  • 74 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $215M of Lumos Pharma, Inc. Common Stock stock for Q2 2013.
  • 74 funds opened new Lumos Pharma, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +74 holders.

Based on aggregated 13F filings for Q2 2013.